Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3A9TZ
|
|||
| Drug Name |
ION582
|
|||
| Synonyms |
BIIB121
Click to Show/Hide
|
|||
| Drug Type |
Antisense oligonucleotide
|
|||
| Indication | Angelman syndrome [ICD-11: LD90.0; ICD-10: Q93.5] | Phase 1/2 | [1] | |
| Company |
Biogen; Ionis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05127226) HALOS: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION582 in Patients With Angelman Syndrome. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.